Report #2835183

Received Apr 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: AZ
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	—

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

never received their 2nd dose due to COVID and pandemic; This non-serious case was reported by a other health professional via sales rep and described the occurrence of social problem in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2020). On an unknown date, the patients did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced social problem (Verbatim: never received their 2nd dose due to COVID and pandemic). The outcome of the social problem was not reported. Additional Information: GSK Receipt Date: 26-MAR-2025 The reporter reported that they had several patients that received 1st dose in 2020 and then never received their 2nd dose due to Covid and pandemic. The reporter asked should these patients restart the series or just get the 2nd dose.